ENTERAL

NIFUROXAZIDE

Public price

14,80 MAD

Active substance

NIFUROXAZIDE

Laboratory

LAPROPHAN

Reimbursable

What is this medicine?

ENTERAL contains NIFUROXAZIDE. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.

Verified summary

NIFUROXAZIDE, GELULE, 200 MG, BOITE DE 12

Common uses

General use context: oral form, with use determined by the doctor or pharmacist according to the situation.

Laboratory

LAPROPHAN

Availability note

Reimbursable

Hospital price

9,20 MAD

Strength

200 MG

Form

GELULE

Presentation

BOITE DE 12

Commercial status

Commercialisé

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2026-06-01: 14,80 MAD

Available presentations and strengths

ENTERAL 200 MG

200 MG · Boîte de 12

14,80 MAD

ENTERAL

200 MG · 1 BOITE 12 GELULE

15,80 MAD

ENTERAL

100 MG · 1 BOITE 12 SACHET

17,20 MAD

ENTERAL

220 MG · 1 FLACON 90 ML

25,70 MAD

ENTERAL

0,044 · FLACON DE 90 ML

25,70 MAD

Medicines with the same active substance

NIFOX

100 MG · BOITE DE 16

10,70 MAD

NIFUROXAZIDE PHARMA

100 MG · BOITE DE 16

10,70 MAD

ROXID

100 MG · BOITE DE 16

10,70 MAD

NIFOX

200 MG · BOITE DE 16

12,10 MAD

NIFOX 200 MG

200 MG · Boîte de 16

12,10 MAD

NIFUROXAZIDE PHARMA

200 MG · BOITE DE 16

12,10 MAD

NIFROZID

200 MG · BOITE DE 16

12,30 MAD

SEPTAZIDE

200 MG · BOITE DE 16

12,60 MAD

DISIAC

200 MG · BOITE DE 16

13,10 MAD

NIFROZID

200 MG · 1 BOITE 16 GELULE

13,20 MAD

SEPTAZIDE

200 MG · 1 BOITE 16 GELULE

13,40 MAD

ANTINAL

200 MG · BOITE DE 14

14,80 MAD